E D Ehrenpreis

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi request reprint Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Gastroenterology 117:1271-7. 1999
  2. ncbi request reprint Treatment of anal fissures with topical nitroglycerin
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, Illinois 60637, USA
    Expert Opin Pharmacother 2:41-5. 2001
  3. ncbi request reprint Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature
    P M Ginsburg
    Department of Gastroenterology, University of Chicago Hospitals, IL 60637, USA
    Ann Med 33:516-25. 2001
  4. doi request reprint Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
    P Deepak
    Department of Gastroenterology, Research Institute, NorthShore University Health System, Evanston, IL 60201, USA
    Aliment Pharmacol Ther 38:388-96. 2013
  5. ncbi request reprint A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis
    P M Ginsburg
    Division of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 16:2115-22. 2002
  6. doi request reprint Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome
    D J Stobaugh
    Center for the Study of Complex Diseases, Research Institute, Department of Gastroenterology, NorthShore University Health System, 1001 University Place, Evanston, IL 60201, USA
    Osteoporos Int 24:1169-75. 2013
  7. ncbi request reprint Review article: current therapeutic options for radiation proctopathy
    J J Hong
    Gastroenterology Division, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 15:1253-62. 2001
  8. ncbi request reprint Retrograde endoscopic delivery of botulinum toxin for anal fissures
    T P Kinney
    University of Chicago Medical Center, Chicago, Illinois 60637, USA
    Endoscopy 38:654. 2006
  9. doi request reprint Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis
    E D Ehrenpreis
    Department of Gastroenterology, Highland Park Hospital, NorthShore University Healthsystem, Highland Park, IL 60035, USA
    Aliment Pharmacol Ther 29:1202-11. 2009

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Gastroenterology 117:1271-7. 1999
    ..Inhibition of tumor necrosis factor is a proposed mechanism for the anti-inflammatory properties of thalidomide. We performed an open-label trial of thalidomide in refractory Crohn's disease...
  2. ncbi request reprint Treatment of anal fissures with topical nitroglycerin
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, Illinois 60637, USA
    Expert Opin Pharmacother 2:41-5. 2001
    ..This review summarises current literature regarding topical nitroglycerin pharmacotherapy for anal fissure...
  3. ncbi request reprint Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature
    P M Ginsburg
    Department of Gastroenterology, University of Chicago Hospitals, IL 60637, USA
    Ann Med 33:516-25. 2001
    ..Special attention is directed towards its history, mechanisms, and proposed role. The recent development of thalidomide analogues is also discussed briefly...
  4. doi request reprint Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
    P Deepak
    Department of Gastroenterology, Research Institute, NorthShore University Health System, Evanston, IL 60201, USA
    Aliment Pharmacol Ther 38:388-96. 2013
    ..The association between inhibition of tumour necrosis factor alpha (TNF-α) and new onset of neurological adverse events (AEs) is unclear...
  5. ncbi request reprint A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis
    P M Ginsburg
    Division of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 16:2115-22. 2002
    ..Mesenteric panniculitis is a rare condition with no standard therapy...
  6. doi request reprint Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome
    D J Stobaugh
    Center for the Study of Complex Diseases, Research Institute, Department of Gastroenterology, NorthShore University Health System, 1001 University Place, Evanston, IL 60201, USA
    Osteoporos Int 24:1169-75. 2013
    ..Screening measures to identify osteoporosis in this group are advised...
  7. ncbi request reprint Review article: current therapeutic options for radiation proctopathy
    J J Hong
    Gastroenterology Division, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 15:1253-62. 2001
    ..Given that formal randomized placebo-controlled studies are lacking for most treatments, the management of these patients is often challenging and unclear. Hence, there is a need for more research and education on radiation proctopathy...
  8. ncbi request reprint Retrograde endoscopic delivery of botulinum toxin for anal fissures
    T P Kinney
    University of Chicago Medical Center, Chicago, Illinois 60637, USA
    Endoscopy 38:654. 2006
  9. doi request reprint Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis
    E D Ehrenpreis
    Department of Gastroenterology, Highland Park Hospital, NorthShore University Healthsystem, Highland Park, IL 60035, USA
    Aliment Pharmacol Ther 29:1202-11. 2009
    ..Sodium phosphate containing colonoscopy preparations may cause electrolyte disturbances and calcium-phosphate nephropathy. Decreased body weight is an unexplored risk factor for complications with sodium phosphate ingestion...